Skip to main content
Back to AI Intelligence Briefing
GovernanceAugust 20, 2026Source: U.S. Food and Drug Administration – CDRH

CDRH New: Discussion Paper and Request for Feedback on Generative AI-Enabled Medical Devices

The FDA’s Center for Devices and Radiological Health has announced a discussion paper and public feedback initiative focused on generative AI-enabled medical devices. The update emphasizes early stakeholder engagement on topics such as clinical risk management, evidence standards, and postmarket surveillance, signaling emerging governance norms for AI tools used in patient care.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.